The effect of weight loss on serum concentration of interleukine-6 (IL-6) and insulin resistance;Wpływ redukcji masy ciała na stȩżenie interleukiny-6 (IL-6) i insulinooporność

Endokrynologia Polska

Volumn 57, Issue 2, 2006, Pages 131-135

  Olszanecka Glinianowicz, Magdalena ^a   Zahorska Markiewicz, Barbara ^a   Kocełak, Piotr ^a   Janowska, Joanna ^a   Holecki, Michał ^a   Semik Grabarczyk, Elzbieta ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Insulin resistance; Interleukine 6; Weight loss

Indexed keywords

INTERLEUKIN 6;

ADIPOCYTE; ADOLESCENT; ADULT; ARTICLE; BLOOD; CLINICAL TRIAL; DOWN REGULATION; FEMALE; HUMAN; INSULIN RESISTANCE; METABOLISM; MIDDLE AGED; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY; WEIGHT REDUCTION;

ADIPOCYTES; ADOLESCENT; ADULT; DOWN-REGULATION; FEMALE; HUMANS; INSULIN RESISTANCE; INTERLEUKIN-6; MIDDLE AGED; OBESITY; WEIGHT LOSS;

EID: 36549038840     PISSN: 0423104X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Duncan BB, Schmidt MI. Chronic activation of the innate immune system may underlie the metabolic syndrome. Sao Paulo Med J 2001; 119: 122-127.
2. Juge-Aubry CE, Henrichot E, Meier CA. Adipose tissue: a regulator of inflammation. Best Pract Res Clin Endocrinol Metab 2005; 19: 547-566. (Pubitemid 41823815)
3. Kitano H, Oda K, Kimura T, Matsuoka Y, Csete M, Doyle J, Muramatsu M. Metabolic Syndrome and Robustness Tradeoffs. Diabetes 2004; 53 (supl. 3): 6-15.
4. Mohamed-Ali V, Goodrick S, Rawesh A i wsp. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-a, in vivo. J Clin Endocrinol Metab 1997; 82: 4196-4200. (Pubitemid 27525539)
5. Vozarova B, Weyer C, Hanson K i wsp.Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion. Obes Res 2001; 9: 414-417. (Pubitemid 33603868)
6. Greenberg AS, Nordan RP, McIntosh J, Calvo JC, Scow RO, Jablons D. Interleukin-6 reduces lipoprotein lipase activity in adipose tissue of mice in vivo and in 3T3-L1 adipocytes: a possible role for interleukin-6 in cancer cachexia. Cancer Res 1992; 52: 2143-2149.
7. Rotter V, Nagaev I, Smith U. Interleukin-6 (IL-6) reduces gene and protein expression of IRS-1 and GLUT4 and is overexpres-sed in human fat cells insulin resistant subjects. Diabetes 2002; 51 (supl 2): 303.
8. Mooney RA, Seen J, Cameron S i wsp. Suppressors of cytokine signaling-1 and-6 associate with and inhibit the insulin receptor. J Biol Chem 2001; 276: 25889-25893.
9. Senn JJ, Klover PJ, Nowak IA, Mooney RA. Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes 2002; 51: 3391-3399. (Pubitemid 35403441)
10. Lyson K, McCann SM. The effects of interleukin-6 on pituitary hormone release in vivo and in vitro. Neuroendocrinology 1991; 54: 262-266.
11. Olszanecka-Glinianowicz M, Zahorska-Markiewicz B, Janowka J, Kocełak P, Holecki M. Zwiekszone stezenie interleukiny-6 (IL-6) u kobiet wiaze sie z otyłoscia, a nie z insulinoopornoscia. Endokrynol Pol 2004; 55: 437-441.
12. Mohamed-Ali V, Goodrick S, Coppack SW i wsp. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-a, in vivo. J Clin Endocrinol Metab 1997; 82: 4196-4200. (Pubitemid 27525539)
13. Pickup JC, Chusney GD, Thomas SM, Burt D. Plasma interleu-kin-6, tumor necrosis factor-a and blood cytokine production in type 2 diabetes. Life Science 200; 67: 291-300. (Pubitemid 30413937)
14. Mohamed-Ali V, Goodrick S, Bulmer K i wsp. Production of soluble tumor necrosis factor receptors by human subcutaneous tissue in vivo. Am J Physiol 1999; 277: 971-975.
15. Hak AE, Pols HA, Stehouwer CD i wsp. Markers of inflammation and cellular adhesion molecules in relation to insulin resistance in nondiabetic elderly: the Rotterdam Study. J Clin En-docrinol Metab 2001; 86: 4398-4405. (Pubitemid 32848565)
16. Vozarova B, Weyer C, Hanson K i wsp. Circulating interleu-kin-6 in relation to adiposity, insulin action, and insulin secretion. Obes Res 2001; 9: 414-417. (Pubitemid 33603868)
17. Bastard JP, Jardel C, Delattre J i wsp. Elevated levels of interleukin-6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J Clin Endocrinol Metab 2000; 85: 3338-3342.